Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy-Reference-Cited by-同舟云学术

Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy

Published:2007-11 Issue:1 Volume:195 Page:e217-e223
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Marcucci Rossella,Gori Anna Maria,Paniccia Rita,Giglioli Cristina,Buonamici Piergiovanni,Antoniucci David,Gensini Gian Franco,Abbate Rosanna

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.

2. Aspirin resistance: what, why and when?;Shantsila;Thromb Res,2007

3. Profile and prevalence of aspirin resistance in patients with cardiovascular disease;Gum;Am J Cardiol,2001

4. Development of aspirin resistance in persons with previous ischemic stroke;Helgason;Stroke,1994

5. Frequency of aspirin resistance in patients with congestive heart failure treated with antecedent aspirin;Sane;Am J Cardiol,2002

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs;Nature Reviews Cardiology;2018-09-24

2. PFA ‐100‐measured aspirin resistance is the predominant risk factor for hospitalized cardiovascular events in aspirin‐treated patients: A 5‐year cohort study;Journal of Clinical Pharmacy and Therapeutics;2017-10-21

3. Effects of baseline and early acquired thrombocytopaenia on long-term mortality in patients undergoing percutaneous coronary intervention with bivalirudin;EuroIntervention;2016-04

4. Combination of P2Y12 reaction unit and percentage of platelet inhibition assessed by VerifyNow P2Y12 assay is a useful predictor of long-term clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention;Thrombosis Research;2016-03

5. A time course study of high on treatment platelet reactivity in acute coronary syndrome male patients on dual antiplatelet therapy;Thrombosis Research;2015-09